Cargando…

Toll-Like Receptors, Their Ligands, and Atherosclerosis

Atherosclerosis is a disease characterized by inflammation in the arterial wall. Atherogenesis is dependent on the innate immune response involving activation of Toll-like receptors (TLRs) and the expression of inflammatory proteins. TLRs, which recognize various pathogen-associated molecular patter...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodgkinson, Conrad P., Ye, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: TheScientificWorldJOURNAL 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720026/
https://www.ncbi.nlm.nih.gov/pubmed/21336459
http://dx.doi.org/10.1100/tsw.2011.36
_version_ 1783284602186498048
author Hodgkinson, Conrad P.
Ye, Shu
author_facet Hodgkinson, Conrad P.
Ye, Shu
author_sort Hodgkinson, Conrad P.
collection PubMed
description Atherosclerosis is a disease characterized by inflammation in the arterial wall. Atherogenesis is dependent on the innate immune response involving activation of Toll-like receptors (TLRs) and the expression of inflammatory proteins. TLRs, which recognize various pathogen-associated molecular patterns, are expressed in various cell types within the atherosclerotic plaque. Microbial agents are associated with an increased risk of atherosclerosis and this is, in part, due to activation of TLRs. Recently considerable evidence has been provided suggesting that endogenous proteins promote atherosclerosis by binding to TLRs. In this review, we describe the role of TLRs in atherosclerosis with particular emphasis on those atherogenic endogenous proteins that have been implicated as TLR ligands.
format Online
Article
Text
id pubmed-5720026
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher TheScientificWorldJOURNAL
record_format MEDLINE/PubMed
spelling pubmed-57200262017-12-21 Toll-Like Receptors, Their Ligands, and Atherosclerosis Hodgkinson, Conrad P. Ye, Shu ScientificWorldJournal Review Article Atherosclerosis is a disease characterized by inflammation in the arterial wall. Atherogenesis is dependent on the innate immune response involving activation of Toll-like receptors (TLRs) and the expression of inflammatory proteins. TLRs, which recognize various pathogen-associated molecular patterns, are expressed in various cell types within the atherosclerotic plaque. Microbial agents are associated with an increased risk of atherosclerosis and this is, in part, due to activation of TLRs. Recently considerable evidence has been provided suggesting that endogenous proteins promote atherosclerosis by binding to TLRs. In this review, we describe the role of TLRs in atherosclerosis with particular emphasis on those atherogenic endogenous proteins that have been implicated as TLR ligands. TheScientificWorldJOURNAL 2011-02-14 /pmc/articles/PMC5720026/ /pubmed/21336459 http://dx.doi.org/10.1100/tsw.2011.36 Text en Copyright © 2011 Conrad Hodgkinson and Shu Ye. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Hodgkinson, Conrad P.
Ye, Shu
Toll-Like Receptors, Their Ligands, and Atherosclerosis
title Toll-Like Receptors, Their Ligands, and Atherosclerosis
title_full Toll-Like Receptors, Their Ligands, and Atherosclerosis
title_fullStr Toll-Like Receptors, Their Ligands, and Atherosclerosis
title_full_unstemmed Toll-Like Receptors, Their Ligands, and Atherosclerosis
title_short Toll-Like Receptors, Their Ligands, and Atherosclerosis
title_sort toll-like receptors, their ligands, and atherosclerosis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720026/
https://www.ncbi.nlm.nih.gov/pubmed/21336459
http://dx.doi.org/10.1100/tsw.2011.36
work_keys_str_mv AT hodgkinsonconradp tolllikereceptorstheirligandsandatherosclerosis
AT yeshu tolllikereceptorstheirligandsandatherosclerosis